CHI Logo

 

Japanese Simple Chinese Traditional Chinese Korean 

Conference Menu

Overview
Pre-Conference Workshop
Day 1
Day 2
Advisors and Faculty
Delegate List
Register 
PDF Download
Posters
Hotel & Travel
Sponsor
Press Pass 
Request Brochure 

Arrive Early to Attend

Protein Kinase Targets
June 1-3, 2009

 

Premier Sponsor

CCG No Tag


 Corporate Sponsors

FUJiFILM LifeSciences

Tripos Resized

Corporate Support Sponsors

CCDC

Schrodinger

Sponsoring Associations

ISCB

Lead Sponsoring Publications

Bio-IT World

Science AAAS

The Scientist

Sponsoring Publications

CBDD

R&D Directions

Pharmavoice

Web Partners

Biolexis

CombiChemLab

PharmCast

SelectScience

CHI's Structure-Based Drug Design

Register Today! 

 

Topics include:

 

  • Target Structure-Guided Drug Discovery
  • Feeding SBDD with Biochemical and Biophysical Information
  • Ligand-Based Predictions Applied to Drug Design
  • SBDD and Computational Chemistry Methods: A Marriage of Innovation
  • SBDD of Pharmacological Chaperons

 

PLUS

Pre-Conference Workshop: Wednesday, June 3

Designing Kinase Inhibitors

Hear from thought leaders including:

 

Structure and Function of the G-Protein Coupled Receptor Family

Raymond C. Stevens, Ph.D., Professor, Departments of Molecular Biology and Chemistry, Scripps Research Institute

Structure-Based and Ligand-Based Computational Modeling of Pharmacological Profiles

Ajay N. Jain, Ph.D., Professor, Cancer Research Institute & Department of Lab Medicine, University of California San Francisco

 

Discovery of Novel Cyclin-Dependent Kinase Inhibitors: A CDK2 Case Study in Structure-Based Drug Design

José Duca, Ph.D., Senior Principal Scientist, 3D-Drug Design Department, Schering Plough Research Institute

 

The Race for Chemical and Biological Space: A Drug Design Perspective

Tomi Sawyer, Ph.D., Chief Scientific Officer, AILERON Therapeutics; Editor-in-Chief, Chemical Biology & Drug Design

 

Predicting the Activity of Congeneric Series

W. Patrick Walters, Ph.D., Senior Research Fellow, Computational Chemistry and Molecular Modeling, Vertex Pharmaceuticals, Inc.

Towards Rational Drug Design for Intrinsically Unstructured Proteins - Small Molecules Mediated Inhibition of a-Synuclein Aggregation

Gergely Toth, Ph.D., Scientist, Computational Chemistry and Biology, Chemistry, Elan Pharmaceuticals

 

 


For questions or suggestions about the meeting, please contact:
Micah Lieberman, Conference Producer
Phone:  541-482-4709
E-mail: mlieberman@pharmaseries.com 

For media partnership opportunities, please contact:
James Prudhomme, Marketing Manager
Phone: 781-972-5486
E-mail: jprudhomme@healthtech.com

For exhibit, partnering and sponsorship information, please contact:
Katelin Fitzgerald, Manager Business Development
Phone: 781-972-5458
Email: kfitzgerald@healthtech.com

By Series:
By Region:

2009 Conference
& Course Catalog

CHI Catalog